Darbepoetin Alfa and Anemia of Cancer

Clinical trial NCT00989092 · TERMINATED

Trial details

NCT number: NCT00989092
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia Anemia of Cancer Cancer Carcinoma Neoplasms Non-Myeloid Malignancies

Start date: 2002-05-01
Primary completion: 2004-01-01
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.